论文部分内容阅读
我们从1992年1月～1996年5月共收治46例晚期原发性肝癌患者,他们均失去手术治疗机会,又不愿接受放疗、介入治疗。经使用华蟾素配合化疗,取得较好疗效,现报道如下。 1 一般资料 88例患者均为Ⅱ、Ⅲ期原发性肝癌患者,随机分为A、B两组。A组46人,其中男35例,女11例,年龄在32～64岁,平均49岁。经CT、B超检测诊为巨块型12例,结节型18例,弥漫型16例。B组42人,其中男32例,女10例,平均年龄48岁。其中巨块型13例,结节型18例,弥漫型11例。所有病例的诊断、分型均符合1997年全国肝癌协会制订的肝癌诊断及分型标准。
From January 1992 to May 1996, we treated 46 patients with advanced primary liver cancer who lost surgical treatment and were reluctant to undergo radiotherapy or interventional therapy. The use of Huachansu with chemotherapy, to achieve better results, are reported below. 1 General Information 88 patients were stage II, III primary liver cancer patients, were randomly divided into A, B groups. A group of 46 people, including 35 males and 11 females, aged 32 to 64 years old, an average of 49 years old. Twelve cases were diagnosed as massive masses by CT and B-ultrasound examinations. There were 18 cases of nodular type and 16 cases of diffuse type. There were 42 patients in group B, including 32 males and 10 females, with an average age of 48 years. Among them, 13 were massive, 18 were nodular, and 11 were diffuse. The diagnosis and classification of all cases met the criteria for diagnosis and classification of liver cancer developed by the National Hepatitis Association in 1997.